Instituto de Salud Pública de Chile (ANAMED)
Chilean regulator (ANAMED sub-department); applies GMP through Norma Técnica N° 127.
What this page does not claim
SPEQ curates and cross-references these bodies. It is not affiliated with, accredited by, or endorsed by any of them, and a count of decoded standards is a measure of SPEQ’s coverage, not of a body’s importance.
WHAT ISP COVERS
The Instituto de Salud Pública de Chile is the national regulator for medicines, with its ANAMED sub-department (Agencia Nacional de Medicamentos) responsible for authorisation and control. GMP is applied through Norma Técnica N° 127, approved by Decreto Exento N° 28 of 2012 and updated by Decreto Exento N° 159 of 2013, under the pharmaceutical control regulation DS N° 3 of 2010.
WHAT ISP PUBLISHES
- 01Norma Técnica N° 127 — the GMP technical standard
- 02Registration and authorisation requirements under DS N° 3/2010
- 03GMP certification outcomes for inspected laboratories
- 04Pharmacovigilance and safety communications
- 05Technical standards covering specific product categories, including advanced therapies
HOW ITS REQUIREMENTS BITE
ISP certifies GMP compliance following on-site inspection, examining facilities, equipment, and daily process records. Certification supports product registration for the Chilean market, and foreign manufacturers must evidence compliance acceptable to ISP.
What practitioners get wrong
- Work from the Decreto Exento N° 159/2013 update of Norma Técnica N° 127, not the 2012 original — the update is the text inspectors apply.
- The standard follows WHO GMP (Reports 32/33, updated per Report 37), so a WHO- or PIC/S-compliant site aligns closely on technical substance.
- ISP certification follows on-site inspection of facilities, equipment, and daily process records — records, not just systems, are examined.
- Spanish-language documentation is expected, and foreign GMP evidence generally needs legalisation to be accepted.
- ANAMED sits inside ISP rather than operating as a separate agency, so medicines authorisation and public-health laboratory functions share one institution.
What an inspection under this authority actually probes
WHERE IT SITS INTERNATIONALLY
Chile’s GMP standard is grounded in WHO GMP reports, and ISP has been designated a WHO-Listed Authority, which supports reliance by other regulators in the region. For a supplier or contract manufacturer already inspected against WHO or PIC/S expectations, the Chilean requirement is recognisable — the effort is in local certification, translation, and evidencing that foreign compliance in a form ISP accepts.
ISP STANDARDS SPEQ DECODES · 1
DISCIPLINES IN ISP’S REMIT
ISP: frequently asked questions
Reference answers on Instituto de Salud Pública de Chile (ANAMED)’s mandate, what it publishes, and how its requirements acquire force.
What is ISP Chile?
The Instituto de Salud Pública de Chile is Chile’s national medicines regulator, with its ANAMED sub-department responsible for authorisation and control. ANAMED sits inside ISP rather than operating as a separate agency, so medicines authorisation and public-health laboratory functions share one institution.
What GMP standard does Chile apply?
GMP is applied through Norma Técnica N° 127, approved by Decreto Exento N° 28 (2012) and updated by Decreto Exento N° 159 (2013). Work from the 2013 update — it is the text inspectors apply — and it follows WHO GMP reports.
How does ISP certify GMP compliance?
ISP certifies compliance following on-site inspection, examining facilities, equipment, and daily process records — records, not just systems, are examined. Certification supports product registration, and foreign manufacturers must evidence compliance acceptable to ISP. ISP has been designated a WHO-Listed Authority.